Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An autoantibody is an antibody produced by the immune system that mistakenly targets and reacts with an individual's own proteins, cells, or tissues (self-antigens), rather than foreign invaders. This loss of self-tolerance is a hallmark of autoimmune diseases, where autoantibodies can serve both as biomarkers and mediators of disease pathology. They can directly damage tissues by binding to cell surface receptors or extracellular matrix components, activating complement pathways, or modulating receptor function. Natural autoantibodies (mainly IgM) are present at low levels and are thought to play roles in immune homeostasis and clearance of cellular debris.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autoantibody (autoAb).